Stock AMGN AMGEN INC.
Add to a list
To use this feature you must be a member
Log inSign up

Group Amgen Inc.

Stock

AMGN

US0311621009

Pharmaceuticals

Market Closed - Nasdaq
Other stock markets
 04:00:00 2025-01-16 pm EST 		5-day change 1st Jan Change
269.43 USD +0.18% Intraday chart for Amgen Inc. +1.98% +3.37%
Jan. 13 Amgen Inc. Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-13-2025 03:00 PM
Jan. 10 Wells Fargo Cuts Price Target on Amgen to $280 From $335, Maintains Equalweight Rating MT

Group Amgen Inc.: Relations chart

Private companies belonging to the same group as AMGEN INC.

CompanyManager
Amgen NV
Logo Amgen NV

Amgen NV

Pharmaceuticals: MajorHealth Technology

Part of Amgen, Inc., Amgen NV is a pharmaceutical company based in Diegem, Belgium. The Belgian company is focused on developing innovative therapies to address serious illnesses and improve the lives of patients. Amgen is committed to advancing scientific research and delivering high-quality medicines to patients worldwide. The CEO of the company is Gabor Sztaniszlav.

 -
Amgen Global Finance BV
Logo Amgen Global Finance BV

Amgen Global Finance BV

MiscellaneousMiscellaneous

Part of Amgen, Inc., Amgen Global Finance BV functions as an investment holding Dutch company. The company is based in Breda, Netherlands.

 -
  1. Stock Market
  2. Equities
  3. AMGN Stock
  4. Company Amgen Inc.
  5. Group